Posted inGenetics Time-Restricted Eating Linked to Improved Huntington’s Disease Markers September 18, 2026 Credit: Justin Paget/ DigitalVision/ Getty Images The first clinical study to understand the potential effects of time-restricted eating in people…
Posted inGenetics Asahi Kasei Introduces VANTIJ® SU-VFC Benchtop Virus-Filtration System September 18, 2026 Initially designed for gene therapy manufacturing, the new benchtop helps address the operational complexities associated with long production timelines, regulatory…
Posted inGenetics GBI Biomanufacturing Set to Launch SmartScale GMP Solutions September 18, 2026 The GBI platform combines technologies from industry partners ATUM and Thomson Instrument to streamline cell line development, process scaleup, and…
Posted inGenetics Model-Free, Pure Component Analysis Could Help Biopharma Cut Costs September 18, 2026 Credit: Bloomberg Creative/ Getty Images Spectroscopy can be used to analyze process streams for proteins and analytes of interest in…
Posted inGenetics Nu-Tek Brings Topic of Raw-Material Risk to BPI September 18, 2026 Credit: Image generated with Google Gemini As biopharmaceutical manufacturers push for tighter process control and more resilient supply chains, raw…
Posted inGenetics The Saga of Sickle Cell Disease September 18, 2026 The approval in December 2023 of Casgevy and Lyfgenia marked a major milestone in the treatment of sickle cell disease…
Posted inGenetics Two-Organ View of the Human Brain Emerges September 18, 2026 Credit: Photo by Robina Weermeijer on Unsplash Scientists have traditionally thought of the brain as a single, unified organ. But…
Posted inGenetics Palomar Labs Spins Out Ariadne Bio to Advance Non-Hallucinogenic Therapy for Parkinson’s Apathy September 18, 2026 Credit: koto_feja / E+/ Getty Images There is considerable room for innovation in neuropsychiatric drug development and Palomar Labs, a…
Posted inBiotechnology With pioneering ADHD data, Alkermes eyes orexin agonist as potential ‘company changer’ September 18, 2026 Following Takeda’s historic approval of the first orexin agonist with its narcolepsy treatment Orzeyful, Alkermes has followed up with pioneering…
Posted inBiotechnology DPHARM: Where to begin with AI in clinical trials? September 18, 2026 The promise of AI to transform the clinical trial process is being realized in fits and starts, but early applications…